Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$3.58 - $10.13 $5,266 - $14,901
-1,471 Reduced 12.34%
10,451 $37,000
Q1 2024

May 14, 2024

BUY
$9.22 - $15.02 $14,060 - $22,905
1,525 Added 14.67%
11,922 $124,000
Q4 2023

Feb 13, 2024

BUY
$6.5 - $12.85 $67,580 - $133,601
10,397 New
10,397 $124,000
Q3 2023

Nov 13, 2023

SELL
$10.45 - $15.02 $63,630 - $91,456
-6,089 Reduced 22.21%
21,327 $225,000
Q2 2023

Aug 14, 2023

BUY
$10.52 - $16.06 $12,655 - $19,320
1,203 Added 4.59%
27,416 $369,000
Q1 2023

May 11, 2023

SELL
$7.32 - $14.38 $71,091 - $139,658
-9,712 Reduced 27.03%
26,213 $376,000
Q4 2022

Feb 13, 2023

SELL
$7.19 - $13.16 $13,589 - $24,872
-1,890 Reduced 5.0%
35,925 $279,000
Q3 2022

Nov 14, 2022

BUY
$0.0 - $12.8 $0 - $484,032
37,815 New
37,815 $432,000

Others Institutions Holding ACCD

About Accolade, Inc.


  • Ticker ACCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 71,938,896
  • Market Cap $496M
  • Description
  • Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...
More about ACCD
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.